File Download
  Patent History
  • Application
    US 10/917195 2004-08-12
  • Publication
    US 2005089895 2005-04-28
Supplementary

published patent: Compositions and methods for prognosis and therapy of liver cancer

TitleCompositions and methods for prognosis and therapy of liver cancer
Priority Date2004-08-12 US 10/917195
2003-08-13 US 10/494981P
2003-09-04 US 10/500844P
Inventors
Issue Date2005
Citation
US Published patent application US 2005089895. Washington, DC: US Patent and Trademark Office (USPTO), 2005 How to Cite?
AbstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDN10 (R54559), DNALI1 (R93087), RBP5 (AA453198), EST3 (AA621761), EST4 (N63706), PCOLCE (AA670200), TDO2 (T72398), EST5 (T47454), HIST1H2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXA1 (H63077), CKB (AA894557), ITGBL1 (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841). This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.
Persistent Identifierhttp://hdl.handle.net/10722/176893

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:41Z-
dc.date.available2012-11-30T08:38:41Z-
dc.date.issued2005-
dc.identifier.citationUS Published patent application US 2005089895. Washington, DC: US Patent and Trademark Office (USPTO), 2005en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176893-
dc.description.abstractThis invention provides a composition comprising the following polynucleotide probes: IL7R (AA485865), NDRG1 (AA486403), EST1 (H50345), TRPC1 (AA017132), GFRA1 (AA512935), EST2 (AA454543), CLDN10 (R54559), DNALI1 (R93087), RBP5 (AA453198), EST3 (AA621761), EST4 (N63706), PCOLCE (AA670200), TDO2 (T72398), EST5 (T47454), HIST1H2BD (N33927), PXMP2 (N70714), ACAS2 (AA455146), ANAPC7 (T68445), EST6 (AA576580), RBP5 (N92148), ANXA1 (H63077), CKB (AA894557), ITGBL1 (N52533), KPNA2 (AA676460), EST7 (W90740) and MEG3 (W85841). This invention further provides methods for determining the likelihood of recurrence of hepatocellular carcinoma (HCC) in a subject afflicted with HCC, for determining the likelihood of death of a subject afflicted with HCC or for determining whether to administer adjuvant therapy.en_HK
dc.relation.isreferencedbyES 2367285 (A1) 2011-11-02en_HK
dc.relation.isreferencedbyES 2367285 (B1) 2012-09-13en_HK
dc.relation.isreferencedbyUS 2011033873 (A1) 2011-02-10en_HK
dc.relation.isreferencedbyUS 2010035971 (A1) 2010-02-11en_HK
dc.relation.isreferencedbyUS 8143029 (B2) 2012-03-27en_HK
dc.relation.isreferencedbyWO 2007063118 (A1) 2007-06-07en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleCompositions and methods for prognosis and therapy of liver canceren_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorCheung, STen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationUS 10/917195en_HK
patents.description.assigneeCHEUNG SIU T, ; FAN SHEUNG Ten_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2005-04-28en_HK
patents.date.application2004-08-12en_HK
patents.date.priority2004-08-12 US 10/917195en_HK
patents.date.priority2003-08-13 US 10/494981Pen_HK
patents.date.priority2003-09-04 US 10/500844Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2005089895en_HK
patents.relation.familyCN 1867671 (A) 2006-11-22en_HK
patents.relation.familyCN 100549172 (C) 2009-10-14en_HK
patents.relation.familyHK 1098783 (A1) 2010-07-02en_HK
patents.relation.familyUS 2009325160 (A1) 2009-12-31en_HK
patents.relation.familyUS 8076077 (B2) 2011-12-13en_HK
patents.relation.familyUS 2005089895 (A1) 2005-04-28en_HK
patents.relation.familyWO 2005017150 (A1) 2005-02-24en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats